X4 Pharmaceuticals (XFOR) Return on Capital Employed Growth (5y) (2023 - 2025)
X4 Pharmaceuticals (XFOR) Return on Capital Employed Growth (5y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | X4 Pharmaceuticals | 167.69 Mn | -49.36 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 842.00 |
| Sep 30, 2025 | -4,662.00 |
| Jun 30, 2025 | -7,317.00 |
| Mar 31, 2025 | 2,712.00 |
| Dec 31, 2024 | 1,302.00 |
| Sep 30, 2024 | 2,749.00 |
| Jun 30, 2024 | 3,365.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 6,707.00 |
| Sep 30, 2023 | -2,904.00 |
| Jun 30, 2023 | -3,573.00 |
| Mar 31, 2023 | -4,516.00 |